Chengdu Shengnuo Biopharm

Chinese pharmaceutical-grade API manufacturer. NMPA (China FDA) certified facilities. Produces peptide active pharmaceutical ingredients and intermediates. Multiple GMP certificates for pharmaceutical production. Ships internationally to regulated markets. Holds a US DMF for tirzepatide (filed 2025); FDA inspection 2023 closed VAI.

Directory assessment: Chengdu Shengnuo Biopharm is listed as a bulk wholesaler in the peptide supply chain, serving Asia markets from China. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.